We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ansell | LSE:ANS | London | Ordinary Share | AU000000ANN9 | NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | - | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/6/2003 07:07 | LONDON (AFX) - SSL International PLC said that the new year has begun satisfactorily and it is optimistic that the challenges ahead -- completing the major disposals and improving the profitability of its consumer business -- can be met successfully. At the same time, the maker of Durex condoms and Scholl foot products reported that sales rose by 5 pct to 623.9 mln stg, compared with 592.4 mln stg last year in the year to March 31 -- above its own guidance that sales would attain 622 mln stg. Pretax profit totalled 39.1 mln stg, up from a loss of 2.9 mln stg, including an exceptional cost of 20 mln stg. SSL said that following a review of the group's operations, it is focusing resources on its consumer healthcare businesses -- which include the Durex and Scholl brands -- and by divesting the medical business, as well as the industrial gloves business. The group said the process of selling the medical business is now well underway and has generated a substantial level of interest. etain.lavelle@afxnew el/shw | waldron | |
30/4/2003 12:23 | SSL was leading the risers after an unexpected and upbeat trading statement, with shares ahead 19 pence to 220. The condoms to corn plasters group said full year sales should come slightly ahead of previous guidance, helped up by better-than-expected performance at its consumer sales unit. SSL also said the disposal of its medical business is now well under way with further details scheduled for June. This boosted hopes the company is in talks with a potential buyer; Dresdner KW kept a 'buy' recommendation. | waldron | |
13/2/2003 08:43 | SSL is a major competitor,me thinks LONDON (AFX) - SSL International PLC said it has launched Biogel Skinsense PI, the next generation synthetic surgical glove from Regent Medical, its surgical gloves division. The new product will be available, initially in the US, from March 2003. The glove is made from polyisoprene, which has fit, feel and comfort characteristics comparable to latex gloves but without concerns about allergies to natural rubber latex proteins. It said it has been designed to help eliminate the disadvantages of stiffness, lower elasticity and tendency to deform found in some other synthetic gloves. The new glove and the production process have been under test for six months. rn | waldron | |
13/2/2003 08:30 | Maywillow,As usual,you are no doubt right. But this is a real gossamer company. | waldron | |
13/2/2003 08:16 | Take a look at this thread. | maywillow | |
13/2/2003 08:13 | Good Morning Waldron, Thought you were sticking to European Shares and especially with those you know. Ozzies and Kiwis are great but perhaps theres a better share closer to home. | maywillow | |
13/2/2003 07:49 | Surprised to see that an Australian maker of Medical Gloves has slipped its way in to the Advfn Arena. Would be interesting to know whether any posters out there are familiar with this company called Ansells LD. | waldron |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions